Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Terminated Phase 1 Trials for Dexamethasone (DB01234)

Back to Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
IndicationStatusPhase
DBCOND0029297 (Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01088763Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTreatment